Source:http://linkedlifedata.com/resource/pubmed/id/20298757
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-4-12
|
pubmed:abstractText |
Exercise preconditioning has been shown to reduce neuronal damage in ischemic/reperfusion (I/R) injury. ERK1/2 signaling in injury has been thought to modulate neuroprotection. In this study, we investigated the effects of ERK1/2 activation on the expression and activity of MMP-9 and downstream neuronal apoptosis. Adult male Sprague-Dawley rats were subjected to 30min of exercise on a treadmill for 3 weeks. Stroke was induced by a 2-h middle cerebral artery (MCA) occlusion using an intraluminal filament. Apoptotic protein caspase-3 and neuronal apoptosis in cortex and striatum was determined by Western blot at 24h reperfusion and TUNEL staining at 48h reperfusion in 5 I/R injury groups: no treatment, MMP-9 inhibitor (doxycycline), pre-ischemic exercise, exercised animals undergone ERK1/2 inhibition (U0126), and dual inhibition of ERK1/2 and MMP-9 in exercised ischemic rats. Cerebral MMP-9 expression in ischemic rats with different treatment was determined at 6, 12 and 24h reperfusion by real-time PCR for mRNA, Western blot for protein and zymography for enzyme activity. Exercise preconditioning significantly (p<0.05) reduced apoptosis determined by caspase-3 and TUNEL. In non-exercised rats, doxycycline treatment had significant (p<0.05) reductions in apoptosis after I/R injury. The dual ERK1/2-MMP-9 inhibited exercised animals had significantly (p<0.05) reduced neuronal apoptosis that was similar to that seen in exercised ischemic rats. MMP-9 expression in I/R injury was significantly (p<0.05) reduced in the exercised animals as compared to non-exercised controls. When ERK1/2 was inhibited, the reduced MMP-9 expression was reversed to the level seen in the non-exercised controls. This study has suggested that exercise-induced neuroprotection in I/R injury may be mediated by MMP-9 and ERK1/2 expression, leading to a reduction in neuronal apoptosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Butadienes,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/U 0126
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1872-7972
|
pubmed:author |
pubmed-author:CarranzaAaronA,
pubmed-author:ChaudhryKhawarK,
pubmed-author:CurryAleciaA,
pubmed-author:DingYuchuanY,
pubmed-author:GeeD ADA,
pubmed-author:GoelGunjanG,
pubmed-author:JiXunmingX,
pubmed-author:JimenezDavid FDF,
pubmed-author:LiebeltBrandonB,
pubmed-author:OmidRR,
pubmed-author:RogersRyanR
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
474
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
109-14
|
pubmed:meshHeading |
pubmed-meshheading:20298757-Analysis of Variance,
pubmed-meshheading:20298757-Animals,
pubmed-meshheading:20298757-Apoptosis,
pubmed-meshheading:20298757-Brain,
pubmed-meshheading:20298757-Butadienes,
pubmed-meshheading:20298757-Caspase 3,
pubmed-meshheading:20298757-Disease Models, Animal,
pubmed-meshheading:20298757-Doxycycline,
pubmed-meshheading:20298757-Enzyme Inhibitors,
pubmed-meshheading:20298757-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:20298757-In Situ Nick-End Labeling,
pubmed-meshheading:20298757-Infarction, Middle Cerebral Artery,
pubmed-meshheading:20298757-Male,
pubmed-meshheading:20298757-Matrix Metalloproteinase 9,
pubmed-meshheading:20298757-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:20298757-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:20298757-Nitriles,
pubmed-meshheading:20298757-Physical Conditioning, Animal,
pubmed-meshheading:20298757-Rats,
pubmed-meshheading:20298757-Rats, Sprague-Dawley,
pubmed-meshheading:20298757-Reperfusion,
pubmed-meshheading:20298757-Time Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke.
|
pubmed:affiliation |
Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, MI 48201, United States.
|
pubmed:publicationType |
Journal Article
|